Gijsbert G. Bon

Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values

Gijsbert G. Bon, Peter Kenemans, Rob A. Verstraeten et al. · American Journal of Obstetrics and Gynecology · 1996 · 95 citations

Cancer Detection, Medicine, Gynecology +6

Fluctuations in CA 125 and CA 15 3 serum concentrations during spontaneous ovulatory cycles

Gijsbert G. Bon, Peter Kenemans, J.J. Dekker et al. · Human Reproduction · 1999 · 70 citations · Full text

Hormonal Contraceptive, Spontaneous Menstrual Cycles, Fertility +19

Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.

Gijsbert G. Bon, Silvia von Mensdorff‐Pouilly, Peter Kenemans et al. · PubMed · 1997 · 53 citations

Tumor Biology, Breast Oncology, Oncology +15

Clinical and technical evaluation of ACS™BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays

Gijsbert G. Bon, Silvia von Mensdorff‐Pouilly, Peter Kenemans et al. · Clinical Chemistry · 1997 · 49 citations · Full text

Muc1 Gene-derived Glycoprotein, Breast Oncology, Oncology +15

Carcinoma‐associated mucin serum markers CA M26 and CA M29: Efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix

Kees A. Yedema, Peter Kenemans, Theo Wobbes et al. · International Journal of Cancer · 1991 · 21 citations